Comparative Quantitative Structure−Activity Relationship Studies on Anti-HIV Drugs
- 17 November 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 99 (12) , 3525-3602
- https://doi.org/10.1021/cr9703358
Abstract
No abstract availableThis publication has 178 references indexed in Scilit:
- QSAR Based on Multiple Linear Regression and PLS Methods for the Anti-HIV Activity of a Large Group of HEPT DerivativesJournal of Chemical Information and Computer Sciences, 1997
- Crystal Structures of 8-Cl and 9-Cl TIBO Complexed with Wild-type HIV-1 RT and 8-Cl TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant MutantJournal of Molecular Biology, 1996
- Molecular simulation of 5,6-substituted 1-[(2-hydroxyethoxy)methyl]uracils with anti-HIV-1 activityEuropean Journal of Medicinal Chemistry, 1996
- 3D-Quantitative Structure-Activity Relationships of Human Immunodeficiency Virus Type-1 Proteinase Inhibitors: Comparative Molecular Field Analysis of 2-Heterosubstituted Statine Derivatives-Implications for the Design of Novel InhibitorsJournal of Medicinal Chemistry, 1995
- Novel Non-nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. 5. 4-Substituted and 2,4-Disubstituted Analogs of NevirapineJournal of Medicinal Chemistry, 1995
- Structure-Based Design of Nonpeptidic HIV Protease Inhibitors from a Cyclooctylpyranone Lead StructureJournal of Medicinal Chemistry, 1995
- A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationshipsJournal of Medicinal Chemistry, 1993
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989
- Effective blocking of HIV‐1 proteinase activity by characteristic inhibitors of aspartic proteinasesFEBS Letters, 1989
- Hydrophobicity and Central Nervous System Agents: On the Principle of Minimal Hydrophobicity in Drug DesignJournal of Pharmaceutical Sciences, 1987